Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioRestorative Therapies (BRTX) Operating Leases (2020 - 2024)

Historic Operating Leases for BioRestorative Therapies (BRTX) over the last 5 years, with Q3 2024 value amounting to $42414.0.

  • BioRestorative Therapies' Operating Leases fell 7865.68% to $42414.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $42414.0, marking a year-over-year decrease of 7865.68%. This contributed to the annual value of $162317.0 for FY2023, which is 0.0% changed from last year.
  • BioRestorative Therapies' Operating Leases amounted to $42414.0 in Q3 2024, which was down 7865.68% from $83580.0 recorded in Q2 2024.
  • In the past 5 years, BioRestorative Therapies' Operating Leases ranged from a high of $544223.0 in Q3 2020 and a low of $42414.0 during Q3 2024
  • Over the past 5 years, BioRestorative Therapies' median Operating Leases value was $317200.0 (recorded in 2021), while the average stood at $303262.2.
  • In the last 5 years, BioRestorative Therapies' Operating Leases changed by 0.0% in 2021 and then crashed by 7865.68% in 2024.
  • BioRestorative Therapies' Operating Leases (Quarter) stood at $363519.0 in 2020, then fell by 17.02% to $301645.0 in 2021, then crashed by 46.19% to $162317.0 in 2022, then changed by 0.0% to $162317.0 in 2023, then tumbled by 73.87% to $42414.0 in 2024.
  • Its last three reported values are $42414.0 in Q3 2024, $83580.0 for Q2 2024, and $123536.0 during Q1 2024.